Navigation Links
Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer
Date:8/26/2014

h multi-vendor compatibility and reproducible data," said Frost & Sullivan Research Director, Advanced Medical Technologies Group, Siddharth Saha. "This is of high relevance in the industry, as tomosynthesis is quickly gaining currency, with 30 percent of the members of the Society of Breast Imaging in the U.S. already using it."

VolparaDose, along with VolparaAnalytics, gives radiologists patient-specific quantitative data to help minimize dose in mammography and tomosynthesis while maintaining image quality. While several market participants offer breast density measurement tools, Frost & Sullivan confirms that Volpara Solutions is the only company with a dose measurement tool specifically for breast imaging. It is necessary to measure volumetric breast density to control the dose, and Volpara Solutions has emerged as a pioneer in leveraging the Mega Trend of Dose Reduction by acknowledging patient-specific dose tracking and reporting as a white-space opportunity.

Furthermore, by enabling radiologists to track density and dose scores across time, Volpara Solutions helps support the movement toward the personalization of breast screening. Women with lower density have a lower risk of breast cancer, and researchers are looking at incorporating breast density into risk models that may support personalized screening protocols, which can include the best adjuvant imaging options for that woman (including breast tomosynthesis, automated whole breast ultrasound, molecular breast imaging, and breast MRI) as well as the frequency of screening.

"We are very proud to be recognized for the innovative solutions we have brought to the breast imaging market and for our vision and commitment to address unmet needs in the detection, prevention and treatment of breast cancer," noted Ralph Highnam, Ph.D., Volpara Solutions' CEO and chief scientist. "By allowing researchers across the globe to com
'/>"/>

SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
2. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
3. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
4. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
5. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
6. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
7. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
8. Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform
9. Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging
10. Frost & Sullivan Finds Wellness and Early Intervention Technologies Core Components in Healthcare Delivery Transformation
11. Frost & Sullivan Acknowledges Nanomades Unique Technology that Combines Multipoint Touch and Force Sensing on a Fully Flexible Substrate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... PARSIPPANY, N.J., July 7, 2011 Watson Pharmaceuticals, Inc. ... United States Court of Appeals for the Federal Circuit ... Southern District of Florida,s February 2011 decision that Watson,s ... Mucinex(R) DM (Dextromethorphan HBr/ Guaifenesin) Extended-Release products do not ...
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed an Abbreviated New Drug Application ... (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. ... of Shire LLC,s Vyvanse®. Vyvanse® is a prescription ...
Cached Medicine Technology:Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit 2Watson Confirms Vyvanse® Patent Challenge 2
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that can ... for those same twenty-plus years, the team at Doctors on ... the best possible doctor. With the combined breadth of ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Milan, Altarum Institute VP and Chairman of the Black ... Speaker at Mexico City Business Council on AIDS, ... of,Altarum Institute and a prominent leader and advocate on ... on AIDS conference,Thursday, August 7th in Mexico City. The ...
... the wrong strains during flu season, the FDA should ... other changes to the vaccine composition, according to a ... of the Institute for Operations Research and the Management ... Influenza Vaccine Composition" is by Laura J. Kornish of ...
... Patient Safety Technology, HONOLULU, Aug. 5 ... Queen,s Medical Center will equip 100 additional ... Vigilance Systems,(LifeBed), bringing the total number LifeBed,s ... transforms any bed into a LifeBed, which,invisibly ...
... ... - Adjusted Diluted EPS(1) ... Full-Year 2008 Earnings Estimate - - Conference Call Scheduled ... WST ) today announced results for the second quarter,of 2008. Reported diluted earnings per share of $0.82 ...
... MONTREAL, Aug. 5 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the third quarter, ended,June 30, ... Highlights: - Grew revenue in Q3 2008 ... comparable electrophysiology (EP) revenue in Q3 ...
... Backlog Reaches $72 ... Million ... Recently-introduced Odyssey System Building Strong Market Momentum, ST. LOUIS, Aug. 5 ... 2008. Revenue for the recent second quarter increased 36% to $10.7,million compared with ...
Cached Medicine News:Health News:New decision model seeks to avert flu vaccine mismatch of 2007-2008 season 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:West Announces Second Quarter 2008 Results 2Health News:West Announces Second Quarter 2008 Results 3Health News:West Announces Second Quarter 2008 Results 4Health News:West Announces Second Quarter 2008 Results 5Health News:West Announces Second Quarter 2008 Results 6Health News:West Announces Second Quarter 2008 Results 7Health News:West Announces Second Quarter 2008 Results 8Health News:West Announces Second Quarter 2008 Results 9Health News:West Announces Second Quarter 2008 Results 10Health News:West Announces Second Quarter 2008 Results 11Health News:West Announces Second Quarter 2008 Results 12Health News:West Announces Second Quarter 2008 Results 13Health News:West Announces Second Quarter 2008 Results 14Health News:West Announces Second Quarter 2008 Results 15Health News:West Announces Second Quarter 2008 Results 16Health News:West Announces Second Quarter 2008 Results 17Health News:West Announces Second Quarter 2008 Results 18Health News:West Announces Second Quarter 2008 Results 19Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 12Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 13Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3
... 14A and 14C have been approved. The three ... the variations in the size of the individual ... are designed to stabilize the capsule and have ... of U.S. ophthalmologists. For implatations of the ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Stainless steel cartilage scissors....
Hannum rongeur/grasper with teth in jaws and non-locking design....
Medicine Products: